CORDIS · 952390 · H2020
ESEI-BioMed Enhancing and Strengthening the Excellence in Interdisciplinary Biomedical Research at TRANSCEND
Coordinator: INSTITUTUL REGIONAL DE ONCOLOGIE IASI (RO)
TRANSCEND, designed as a translational research centre at the Regional Institute of Oncology (IRO), an university hospital, due to the EU Structural Funds, is in a emergent stage of its development. The centre, planned to generate a translational repertoire of biomarkers capable to develop the diagnostic tumor taxonomy and to keep going the personalized therapy, was founded on the interdisciplinary interplay between several cell and molecular high-throughput technologies. It therefore offers a stimulating and dynamic scientific and clinical environment to reach its maximum potential by extend…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €2.5M awarded to the consortium. The project runs over approximately 6 years from 2021-01-01 to 2026-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from RO
see all →- CARMINE — Climate-Resilient Development Pathways in Metropolitan Regions of Europe101137851 · HORIZON · €10.2M
- CVDLINK — A federated paradigm of real-world data sources utilization for the empowerment of diagnosis, prognosis and risk assessment of cardiovascular conditions101137278 · HORIZON · €9.7M
- DOORS — Developing Optimal and Open Research Support for the Black Sea (DOORS)101000518 · H2020 · €9.0M
- EUTOPIA_HEALTH — Empowering Widening universities in EUTOPIA_HEALTH consortium to foster academic excellence in Health101136914 · HORIZON · €5.0M
- UNICORE — A Common Code Base and Toolkit for Deployment of Applications to Secure and Reliable Virtual Execution Environments825377 · H2020 · €4.3M
- OptFor-EU — OPTimising FORest management decisions for a low-carbon, climate resilient future in EUrope101060554 · HORIZON · €4.3M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the CSA funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.5M toward a total project budget of €2.5M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-WIDESPREAD-2018-2020.
- Who coordinates the project?
- The project is coordinated by INSTITUTUL REGIONAL DE ONCOLOGIE IASI (RO).
- What is the project timeline?
- The project runs from 2021-01-01 to 2026-12-31 — approximately 6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 952390.